{
    "clinical_study": {
        "@rank": "92602", 
        "arm_group": [
            {
                "arm_group_label": "0% Nitrous oxide", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "10% nitrous oxide", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "20% nitrous oxide", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "30% nitrous oxide", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "40% nitrous oxide", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to conduct experiments to examine subjective and reinforcing\n      effects of nitrous oxide.  Mood altering and psychomotor effects will be tested on non-drug\n      abusers and preference procedures will be used to assess reinforcing effects. To examine\n      differential acute tolerance development to effects of nitrous oxide in humans."
        }, 
        "brief_title": "Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7", 
        "completion_date": {
            "#text": "May 1996", 
            "@type": "Actual"
        }, 
        "condition": [
            "Opioid-Related Disorders", 
            "Substance-Related Disorders"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Opioid-Related Disorders", 
                "Substance-Related Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Please contact site for information."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "37 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000255", 
            "org_study_id": "NIDA-08391-7", 
            "secondary_id": [
                "R01DA008391", 
                "R01-08391-7"
            ]
        }, 
        "intervention": {
            "arm_group_label": [
                "0% Nitrous oxide", 
                "10% nitrous oxide", 
                "20% nitrous oxide", 
                "30% nitrous oxide", 
                "40% nitrous oxide"
            ], 
            "intervention_name": "Nitrous oxide", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Nitrous Oxide"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 23, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60637"
                }, 
                "name": "University of Chicago, Anesthesia & Critical Care"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "5", 
        "official_title": "Differential Acute Tolerance Development to Effects of Nitrous Oxide", 
        "overall_official": {
            "affiliation": "University of Chicago", 
            "last_name": "James Zacny, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "May 1996", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Subjects will inhale varying conc of nitrous oxide for 120 min with cold immersion of forearm at 25, 70, and 115 min and 40 min after inhalation.  Pain intensity and bothersomeness will be assessed at each immersion.", 
            "measure": "Pain intensity, pain bothersomeness", 
            "safety_issue": "No", 
            "time_frame": "25, 70, & 115 min of inhalation and 40 min post"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000255"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Chicago", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Chicago", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 1995", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }, 
    "geocoordinates": {
        "University of Chicago, Anesthesia & Critical Care": "41.878 -87.63"
    }
}